Navigation Links
Horizon Therapeutics Names Dr. Jeffrey W. Sherman Executive Vice President and Chief Medical Officer
Date:6/29/2009

--Dr. Sherman also elected President of the Drug Information Association (DIA)--

NORTHBROOK, Ill., June 29 /PRNewswire/ -- Horizon Therapeutics, Inc., a privately held biopharmaceutical company, today announced the appointment of Jeffrey W. Sherman, M.D., F.A.C.P., as its executive vice president and chief medical officer.

Dr. Sherman brings more than 20 years of pharmaceutical experience to Horizon and will lead the regulatory and clinical strategy for Horizon's investigational therapies for mild-to-moderate arthritis and pain, including HZT-501, a fixed-dose combination tablet containing the most prescribed non-steroidal anti-inflammatory drug (NSAID), ibuprofen, with a high dose of the most potent H2 antagonist, famotidine. HZT-501 was shown to significantly reduce the incidence of NSAID-induced upper gastrointestinal ulcers in patients with mild-to-moderate pain in two Phase 3 studies.

Dr. Sherman joins Horizon from IDM Pharma, which was recently purchased by Takeda Pharmaceuticals Limited, where he led the clinical, regulatory, and development teams that secured European Commission approval for MEPACT(R) (mifamurtide, L-MTP-PE), a treatment for non-metastatic, resectable osteosarcoma. Prior to IDM Pharma, Dr. Sherman served as vice president of clinical science at Takeda Global Research & Development Center, Inc., a subsidiary of Takeda Pharmaceutical Company Limited, where he was focused on developing Takeda's oncology pipeline. Dr. Sherman also held the position of chief medical officer and executive vice president at NeoPharm, Inc., and held numerous research development and marketing roles at Searle/Pharmacia, including responsibility for the COX-2 (Celebrex) oncology program.

"Dr. Sherman has significant experience in the biotechnology and pharmaceutical industry, with a proven track record of success in bringing drugs through the regulatory process," said Timothy P. Walbert,
'/>"/>

SOURCE Horizon Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related biology technology :

1. AGA Institute and Horizon Therapeutics Launch Connect to Protect Program to Educate Physicians and Consumers on Risks Associated With NSAID Use
2. Horizon Therapeutics Selected to Present at InsideVentures Debut Investor Conference March 25-26, Santa Barbara, California
3. Horizon Therapeutics Announces Senior Management Appointments
4. Horizon Therapeutics Names Robert J. De Vaere Executive Vice President and Chief Financial Officer
5. Horizon Therapeutics to Present at JMP Securities Healthcare Focus Conference
6. Horizon Therapeutics to Present at UBS Global Life Sciences Conference
7. Horizon Therapeutics Announces Corporate Relocation to the Chicago Area
8. BioHorizons Global Symposium 2008 Combines Record Attendance with Groundbreaking Technology
9. BioHorizons Announces the Purchase of Implant Logic Systems
10. Caliper Life Sciences Forms Alliance With Horizon Discovery to Provide Enhanced Solutions for Cancer Research Based on Isogenic Cell Lines
11. Biotech Pioneer William J. Rutter to Deliver Keynote at 2008 RAPS Horizons Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)..., Dec. 2 Nearly 600 med...s, and funders today convened to explore novel dev...ies at the inaugural Partnering for Cures meetin...er of the Milken Institute, convened Partnering f...s needed to turn a scientific discovery into an ac...
(Date:12/2/2009)...LGARY, Dec. 2 /PRNewswire-FirstCall/ - Oncolytics ...ONC; NASDAQ: ONCY ) announced today that in connec...the underwriters have exercised in full their over...500 units. Each unit is comprised of one common sh...d was sold at a price of US$3.00 per unit. Each wh...
(Date:12/2/2009)...BRIDGE, Mass., Dec. 2 TechConnect ...echnology development and product integration in c...e December 11th deadline for technology abstracts ...year, TechConnect World, in association with the N...he Clean Technology and Sustainable Industries Org...
(Date:12/2/2009)...STON, Va., Dec. 2 /PRNewswire-Asia-FirstCall/ -- E...y") (OTC Bulletin Board: EMDY), a leading,producer... milk powder and,soybean products in China, today ... Spring issue of US Food & Drink Executive, a ...00 executives in the food and beverage industry. ,...
Breaking Biology Technology:Medical Research Leaders Explore Novel Strategies to Expedite the Search for Cures 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 3Emerald Dairy To Be Featured in Spring Issue of US Food and Drink Executive 2
...G, N.J., April 17 LifeCell,Corporation (Nasdaq: ...rter,2008 operating results on Thursday, April 24,... and Chief Executive Officer, will host a conferen...any,s first quarter 2008,financial results., The .../domestic or,(719) 325-4880/international. A simul...
...ces Institute for Regenerative Medicine to Develop...d Service Members, CLEVELAND, April 17 Cleveland...two civilian research consortia to develop,innovat... service members.,Cleveland Clinic will receive mo...awarded over 5 years to create a new institute cal...
...m Wins Grant to Form New Armed Forces Institute of...(AFIRM), CANTON, Mass. and WASHINGTON, April 17 ...generative medicine company, announced,today that ...nstitute for,Regenerative Medicine at Wake Forest ...n awarded $42.5 million over five years by the U.S...
Other Biology Technology:LifeCell Corporation Schedules First Quarter 2008 Financial Results Conference Call; April 24, 2008 at 10:00 A.M. Eastern 2Cleveland Clinic and Rutgers to Lead Newly Formed Institute for War Wounded 2Cleveland Clinic and Rutgers to Lead Newly Formed Institute for War Wounded 3Organogenesis, Inc. to Develop Regenerative Medicine Therapies for U.S. Military Battlefield Injuries 2Organogenesis, Inc. to Develop Regenerative Medicine Therapies for U.S. Military Battlefield Injuries 3Organogenesis, Inc. to Develop Regenerative Medicine Therapies for U.S. Military Battlefield Injuries 4
(Date:12/2/2009)... , PHILADELPHIA Less acculturated Latino men h...ose who are more acculturated to U.S. culture, but...itting smoking. Details of these findings are publ...tion , a journal of the American Association for C...ocus on tobacco. , "Acculturation affects smokin...
(Date:12/2/2009)... , PHILADELPHIA Cigarette smoking and alcohol co...rongly predicts the patient,s future risk of death...a new study show a similar effect among those who ... "Most cancer survivors are counseled to quit smok... 21 percent continued to smoke even after their ca...
(Date:12/2/2009)... , PHILADELPHIA Mexican-American adolescents exp...e likely to pick up the habit themselves, and this...ed with smoking initiation, according to new study... smoking in the United States and highlights the g...ion Framework Convention on Tobacco Control, which...
Breaking Biology News(10 mins):Acculturation affects smoking cessation success among Latinos 2Head and neck cancer survivors who use alcohol and cigarettes have increased death risk 2Watching movies featuring characters who smoke negatively influences Mexican-American teens 2Free Online Tools Benefitting Time Starved Cost Conscious Home Cooks 54709 1Free Online Tools Benefitting Time Starved Cost Conscious Home Cooks 54709 2Identification Systems Group Pledges Support for Standardized Patient Health Identification Cards 54706 1Identification Systems Group Pledges Support for Standardized Patient Health Identification Cards 54706 2Identification Systems Group Pledges Support for Standardized Patient Health Identification Cards 54706 3Report 3A Yahoo 21 Also Displaying No Prescription Required non US Internet Pharmacy Ads 54701 1Report 3A Yahoo 21 Also Displaying No Prescription Required non US Internet Pharmacy Ads 54701 2Report 3A Yahoo 21 Also Displaying No Prescription Required non US Internet Pharmacy Ads 54701 3
...I. [Brown University] Coastal dead zones, an incr... and the public, may not be as devoid of life afte... do indeed support marine life, and that at least ...rom oxygen-depleted waters. , Andrew Altieri, a p...gy and Evolutionary Biology at Brown University, s...
...researchers at the Johns Hopkins Bloomberg School ...taking the antiretroviral drug efavirenz were more...experience virologic failure and death compared to...t frequently prescribed drug for patients undergoi...r the treatment of HIV/AIDS in sub-Saharan Africa,...
... National Institutes of Health has awarded $4 mill...ts, including The Academy of Natural Sciences, to ... technology from marine mollusks for development i... in the Philippine archipelago, whose waters are i...ciesabout a fifth of all the known speciesand are ...
Other Biology News:Brown scientist finds coastal dead zones may benefit some species 2Brown scientist finds coastal dead zones may benefit some species 3Efavirenz-based initial therapies associated with better outcomes in HIV-infected adults 2Academy participates in project to discover drugs, biofuels in tropical seas 2
...ffers a dedicated system for SFC and SFE applicati...instrumentation. JASCO has recently added the foll...tem: ,- The PU-1580-CO2 delivery pump for supercri...es using carbon dioxide as the mobile phase. ,- Th...
... medium was originally formulated to support the g... gum moth,Antherea eucalypti. The medium is a modi...eAnthereahemolymph. The cell lines established by ...lines developed. The basal medium, when properly s...
CERTOMAT R from Sartorius AG
Vsp I from Promega
Biology Products: